Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PRTX-100: Phase Ib ongoing

Protalex will continue a placebo-controlled, U.S. and South African Phase Ib trial of weekly

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE